St John's Wort
It works. That is exactly why it's dangerous.
For mild-to-moderate depression, St John's Wort has moderate-to-good randomised evidence of benefit over placebo and comparable efficacy to standard antidepressants with a lower side-effect burden. For severe depression the evidence is weak. Two things sharply limit any recommendation: preparations are not standardised, so the trials do not reliably describe what is in the bottle; and it induces CYP3A4 and P-glycoprotein, causing clinically serious interactions with a long list of common and critical medications. It should never be combined with an SSRI, and never taken without telling a clinician what else you take.
How confident is BioSignal?
Our overall position, and how sure we are of it across each dimension — including where we are not sure at all.
Moderate confidence
For mild-to-moderate depression, St John's Wort has moderate-to-good randomised evidence of benefit over placebo and comparable efficacy to standard antidepressants with a lower side-effect burden. For severe depression the evidence is weak. Two things sharply limit any recommendation: preparations are not standardised, so the trials do not reliably describe what is in the bottle; and it induces CYP3A4 and P-glycoprotein, causing clinically serious interactions with a long list of common and critical medications. It should never be combined with an SSRI, and never taken without telling a clinician what else you take.
Promising evidence that is still developing or context-dependent.
Biological Role
Hypericin and hyperforin are the leading active constituents, with hyperforin implicated in both the antidepressant effect and the enzyme induction that makes it dangerous. The mechanism is multi-target and not fully resolved.
Human Evidence
Substantial by supplement standards: dozens of randomised trials and systematic reviews, including active-comparator trials against SSRIs. This is far more than most herbals can claim.
Supplement Benefit
Superior to placebo and comparable to standard antidepressants in mild-to-moderate depression. Evidence in severe depression is weak.
Broader Claims
Claims for anxiety, ADHD, menopausal symptoms, and general 'mood support' are not established at anything like the same standard.
Safety Confidence
Well tolerated on its own — and the interaction profile is severe. The danger is not what it does to you; it is what it does to your other medications.
Research Activity
The core efficacy question has been well studied. Interest has faded, partly because there is no patent to defend.
Where the evidence stands today
How mature the science is, what kinds of evidence exist, and — the part nobody else prints — what is still missing.
8/9
steps proven in humans
Evidence-rich
Proven at every applicable step — rare, and worth noticing.
Guideline / regulatory support
LimitedLicensed for mild-to-moderate depression in parts of Europe; not recommended in US guidelines, largely because of interactions and standardisation.
Clinical outcomes
ProvenSuperior to placebo in mild-to-moderate depression; not established in severe.
Large human RCTs
ProvenIncluding active-comparator trials against SSRIs.
Small human outcome trials
ProvenNumerous.
Human safety data
ProvenWell tolerated alone; serious interaction profile.
Human biomarker / pharmacology
ProvenEnzyme induction demonstrated in humans — the basis of the interaction risk.
Animal
ProvenSupportive.
Cell / in vitro
ProvenWell characterised, including potent CYP3A4 induction.
Mechanistic plausibility
ProvenMulti-target monoaminergic activity; hyperforin implicated.
The bottom line
What we know, what we think, what we don't know — and what would change our mind.
What We Know
In mild-to-moderate depression, St John's Wort beats placebo and matches standard antidepressants in randomised trials, with fewer side effects. It is also a potent inducer of CYP3A4 and P-glycoprotein, and this has caused documented transplant rejection and contraceptive failure.
What We Think
It is a genuinely active antidepressant that happens to be sold as a gentle herbal remedy — and that mismatch between how it is perceived and what it actually does is precisely where the harm comes from. People do not tell their doctor about a tea-aisle supplement.
What We Don't Know
Which constituents drive the effect, and at what dose. Whether the products on shelves resemble the extracts used in trials — hypericin and hyperforin content varies widely and is rarely verified.
Active Research
Limited. The commercially interesting questions have been answered, and an unpatentable plant attracts little further funding.
What Could Change Our Mind
Reliable standardisation, and a well-powered independent trial outside the German-speaking research base, would strengthen the efficacy case considerably. Nothing would change the interaction problem — that is pharmacology, not evidence quality.
The biggest myth
“It's natural, so it's safe”
This is the most dangerous sentence associated with this plant. St John's Wort is a potent inducer of the CYP3A4 enzyme system and of P-glycoprotein — meaning it accelerates the breakdown of other drugs and lowers their levels in the blood. 'Natural' describes its origin and predicts nothing whatsoever about its pharmacology.
Ask BioSignal
Still have a question about st john's wort?
Answers are retrieved from this record and the rest of the knowledge graph — never generated.
Why people take st john's wort
Popularity is not evidence — but it is not stupid either. This explains the interest on its own terms.
St John's Wort is the exception that proves BioSignal is doing evaluation rather than posturing: a supplement with real randomised evidence, which we will say plainly. It is also the clearest demonstration in the whole catalogue that 'natural' is not a safety claim — because the very potency that makes it work is what makes it strip the contraceptive pill and the immunosuppressant of their effect. Something can be genuinely effective and genuinely dangerous, and it takes a knowledge system rather than a headline to hold both.
If you're here because…
Jump straight to the part of the evidence that answers your question.
Approval, safety and regulatory
What it is approved for, who should be careful, what remains unknown — and the limits of what this evidence can tell you.
Regulatory status
Not FDA-approved (sold as a dietary supplement in the US). A licensed medicine for mild-to-moderate depression in some European countries
Availability
Over-the-counter supplement in the US and UK; prescription medicine in parts of Europe
Sport (WADA)
Not a prohibited class (confirm at publication)
Known safety profile
Taken alone, St John's Wort is well tolerated — better tolerated than standard antidepressants in trials, with less nausea and notably less sexual dysfunction. Its danger lies almost entirely in interaction, not in direct toxicity. That combination — feels harmless, behaves like a drug — is exactly what makes it hazardous, because it is the profile least likely to be disclosed to a clinician.
Common issues
- Gastrointestinal upset
- Dizziness and fatigue
- Photosensitivity, particularly at higher doses
- Restlessness
Use caution if
- Anyone taking hormonal contraception (reduced effectiveness; pregnancy reported)
- Anyone taking an SSRI or SNRI (serotonin syndrome risk — do not combine)
- Transplant recipients on immunosuppressants such as ciclosporin or tacrolimus (documented rejection)
- Anyone on warfarin or other anticoagulants
- People taking HIV antiretrovirals or certain chemotherapy agents
- People taking digoxin, statins, or many other CYP3A4 substrates
- People with bipolar disorder (risk of switching to mania)
- Pregnancy and breastfeeding (insufficient data)
Long-term unknowns
Long-term efficacy and safety beyond typical trial durations of 4–12 weeks are not well characterised.
Limits of this evidence
Two limitations are structural. Preparations are not standardised, so the trial evidence describes specific extracts rather than the category — and the retail market does not reliably reproduce them. And the geographic discrepancy in trial results, with German-language studies reporting larger effects, remains unexplained. BioSignal reports both rather than presenting the efficacy finding as cleaner than it is.
Full regulatory and sport detail
- Regulatory approval
- Not FDA-approved. Sold as a dietary supplement in the US and therefore not subject to pre-market efficacy or content verification.
- Approved indication
- None in the US. Licensed for mild-to-moderate depression in some European jurisdictions.
- Research chemical
- N/A — a widely sold botanical supplement.
- Sport (WADA)
- Not a prohibited class — confirm against the current list.
- Publication note
- The drug-interaction profile is the operative regulatory fact and should be foregrounded in any surface that links here. Re-confirm interaction listings at publication.
Demand, separated from evidence
Every claim people make about this, counted against what the evidence actually showed.
BioSignal evaluated 8 popular claims about st john's wort.
Here is where each one landed — including the claims of harm, where “not established” is reassuring rather than damning.
- Supported by evidence
- 3
- Mixed evidence
- 1
- Insufficient evidence
- 1
- Not established
- 3
Popularity is not evidence. This is simply a count of every claim BioSignal evaluated on this page, sorted by what the evidence actually showed — the full reasoning behind each verdict is in the Evidence Review below.
Supported by evidence
- St John's Wort works for mild-to-moderate depression
- It interferes with other medications
- It is well tolerated
Mixed evidence
- It is as effective as prescription antidepressants
Insufficient evidence
- It works for severe depression
Not established
- It's natural, so it's safe
- It can be combined with an SSRI
- One bottle is much like another
The evidence review
Every claim with the reasoning behind its verdict, the doses actually studied, where scientists agree and disagree, and the questions still open.
What people claim
Every popular claim, with BioSignal’s verdict and how confident we are in it. The verdicts are always visible; open any claim to read the evidence behind it.
St John's Wort works for mild-to-moderate depressionSupportedModerate confidence
Yes — and BioSignal says so without hedging, because the evidence deserves it. Systematic reviews of randomised trials find it superior to placebo and comparable in efficacy to standard antidepressants in mild-to-moderate major depression, with fewer adverse effects. Among herbal supplements this is exceptional. The caveats are about standardisation and interactions, not about whether the plant is active.
It works for severe depressionInsufficient evidenceLimited evidence
The evidence here is weak and inconsistent, and severe depression is precisely the situation in which experimenting with an unstandardised product is least wise. Do not substitute it for treatment in severe illness.
It is as effective as prescription antidepressantsMixedModerate confidence
In head-to-head trials in mild-to-moderate depression, broadly yes — with a better tolerability profile. But trials conducted in German-speaking countries have reported systematically more favourable results than those conducted elsewhere, and that discrepancy is unexplained and must be stated rather than ignored. Treat 'as effective' as plausible, not proven.
It interferes with other medicationsSupportedHigh confidence
Severely, and this is the central safety fact of the record. It reduces the effectiveness of hormonal contraceptives (breakthrough bleeding and pregnancy have been reported), immunosuppressants such as ciclosporin (documented organ-transplant rejection), some HIV antiretrovirals, warfarin, certain chemotherapy agents, digoxin, and more. If you take any prescription medication, do not take St John's Wort without telling your clinician.
It can be combined with an SSRINot establishedHigh confidence
No. Combining St John's Wort with an SSRI or SNRI raises the risk of serotonin syndrome — a potentially life-threatening reaction. It should not be taken alongside prescription antidepressants, and 'topping up' a prescription with a herbal is exactly the wrong instinct.
One bottle is much like anotherNot establishedModerate confidence
Not at all. Hypericin and hyperforin content varies substantially between products and even between batches. The trials used specific standardised extracts; a supermarket bottle may contain considerably more, or less, of the active constituents than the product that was tested. The evidence does not automatically transfer to what you can buy.
It is well toleratedSupportedModerate confidence
On its own, yes — better tolerated than standard antidepressants in trials, with less nausea and less sexual dysfunction. This is a real advantage, and it is also what lulls people into taking it without mentioning it to anyone.
Doses used in human studies
What was actually given to participants in the research. These are descriptions of studies, not recommendations.
Mild-to-moderate depression (as studied)
- Intervention
- Standardised hypericum extract
- Dose
- ~300 mg three times daily (extracts standardised to ~0.3% hypericin)
- Duration
- 4–12 weeks in most trials
- Outcome
- Depression symptom score
- Notes
- The trial dose. Whether a given retail product matches it is frequently unverifiable
Severe depression
- Intervention
- St John's Wort
- Dose
- Not established
- Duration
- Not established
- Outcome
- No reliable benefit demonstrated
- Notes
- Do not substitute for treatment in severe depression
Anyone taking prescription medication
- Intervention
- St John's Wort
- Dose
- Not advised without clinical review
- Duration
- N/A
- Outcome
- N/A
- Notes
- CYP3A4 and P-glycoprotein induction. This is the decisive constraint, not a footnote
Anyone taking an SSRI or SNRI
- Intervention
- St John's Wort
- Dose
- Contraindicated
- Duration
- N/A
- Outcome
- N/A
- Notes
- Serotonin syndrome risk. Do not combine
Where scientists agree — and don’t
Agreed
- It is superior to placebo in mild-to-moderate depression.
- It is better tolerated than standard antidepressants.
- It induces CYP3A4 and P-glycoprotein, causing clinically serious drug interactions.
- It should not be combined with SSRIs or SNRIs.
- Commercial preparations are poorly standardised.
Debated
- Whether efficacy genuinely matches prescription antidepressants, given the geographic discrepancy in trial results.
- Which constituents — hypericin, hyperforin, or others — are responsible for the effect.
- Whether it has any role in severe depression (most say no).
Unknown
- The true content of a typical retail product relative to the trial extracts.
- Long-term efficacy and safety beyond the trial durations studied.
What remains unknown
- Why do trials from German-speaking countries report systematically better results than those conducted elsewhere?
- Which constituent actually produces the antidepressant effect — and can it be separated from the enzyme induction that makes the plant dangerous?
- Does the product on the shelf resemble the extract in the trial?
Questions people actually ask
Does St John's Wort actually work?
Yes — for mild-to-moderate depression, and BioSignal is not going to hedge that. Systematic reviews of randomised trials find it superior to placebo, and comparable to standard antidepressants, with fewer side effects. Among herbal supplements this is close to unique, and it matters that we say so: a reviewer who rejects everything is not evaluating evidence, they are performing scepticism. The catch is not whether the plant is active. The catch is everything that follows from the fact that it is.
If it works as well as antidepressants and has fewer side effects, why not just take it?
Because of what it does to your other medicines. St John's Wort induces the CYP3A4 enzyme system and P-glycoprotein, which means it speeds up the clearance of a long list of drugs and quietly strips them of their effect. This is not theoretical: it has caused organ-transplant rejection in people on ciclosporin, and contraceptive failure in people on the pill. It also interferes with warfarin, some HIV medications, some chemotherapy agents, and more. And because it sits on a supermarket shelf next to the vitamins, people do not think to mention it to their doctor — which is exactly how a preventable harm happens.
Can I take it alongside my SSRI?
No. Combining St John's Wort with an SSRI or SNRI raises the risk of serotonin syndrome, which can be serious and occasionally life-threatening. If you are already on a prescription antidepressant, the instinct to add a natural one on top is understandable and it is the wrong move. Talk to your prescriber instead — including if what you actually want is to change or stop the prescription.
Is the bottle I buy the same as what was tested?
Quite possibly not, and this is an underrated problem. The trials used specific standardised extracts, typically around 300 mg three times daily standardised to about 0.3% hypericin. Retail products vary substantially in hypericin and hyperforin content, batch to batch and brand to brand. So the good evidence attaches to a well-characterised extract, and does not automatically transfer to whatever is in front of you. Look for a standardised extract, and know that you are still trusting the label.
So what should I actually do about mild depression?
Take it seriously, and start with the things that have the strongest evidence and the fewest interactions. Psychotherapy — particularly CBT and behavioural activation — is at least as effective as medication in mild-to-moderate depression. Exercise has real, replicated antidepressant effects. Both are first-line for a reason. St John's Wort is a legitimate option to discuss with a clinician, and the operative word is 'discuss', because whether it is safe for you depends entirely on what else you are taking. And if your depression is severe, this is not the page to act on — that is a conversation to have with a doctor now, not later.
Practical takeaways
- It genuinely works for mild-to-moderate depression — one of the few supplements about which BioSignal can say that.
- It is comparable to prescription antidepressants in trials, with fewer side effects.
- It is also a potent drug-interaction hazard: it has caused transplant rejection and contraceptive failure.
- Never combine it with an SSRI — serotonin syndrome is a real risk.
- 'Natural' tells you where it came from. It tells you nothing about what it does.
How it works
The mechanism comes last on purpose. A compelling explanation of how something might work is the easiest part of the story to tell, and the part most likely to outlive the evidence for it.
Hypericin and hyperforin are the leading active constituents, with hyperforin implicated in both the antidepressant effect and the enzyme induction that makes it dangerous. The mechanism is multi-target and not fully resolved.
How we found out
A Traditional Remedy
Hypericum perforatum has been used for centuries for low mood — one of a small number of traditional botanicals that turned out, when tested, to be doing something real.
The Trials
Randomised trials, many conducted in German-speaking Europe where it is a licensed medicine for mild-to-moderate depression, found it superior to placebo and comparable to standard antidepressants with fewer side effects.
The Interactions Emerge
Case reports and pharmacokinetic studies established that St John's Wort is a potent inducer of CYP3A4 and P-glycoprotein. Transplant rejection in patients on ciclosporin, and contraceptive failure, moved it from 'gentle herbal' to a serious clinical interaction hazard.
The Standardisation Problem
Analyses of commercial products found substantial variation in hypericin and hyperforin content — meaning the evidence attaches to specific extracts, not to whatever is on the shelf, while the shelf carries the borrowed credibility of the trials.
References
Verified sources. BioSignal does not print a citation it has not checked.
References for this record are being verified and will be published with the next review. BioSignal does not print citations it has not checked.
Version history
Version 1.0
Initial record (Editorial Expansion, Batch 6). Calibration: Established maturity, moderate confidence in efficacy for mild-to-moderate depression, HIGH confidence in the interaction hazard. This record is deliberately a positive verdict with a serious warning, because that is what the evidence says — and because a review system that never says yes has no credibility when it says no. The geographic discrepancy in trial results and the lack of product standardisation are both stated rather than buried. Review cadence: Annually.
Continue exploring
Three places this record leads next.